Evidence map›Paper›PMID 42328785›Full record

ArticleNucleic acids research2026

Quantitative limits of host-driven HIV transcription and host gene control by the viral transactivator Tat.

Chuan Li, Yuan Ma, Yi Wang, Huiming Yang, Susana T Valente

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chuan LiDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Yuan MaDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Yi WangDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Huiming YangDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.
Susana T ValenteDepartment of Immunology and Microbiology, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, United States.ORCID 0000-0002-7854-7554

Funding

HOPE - HIV Obstruction by Programmed EpigeneticsUM1AI164559 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI Lishomwa C Ndhlovu, Melanie Maria Ott · 2021 to 2026
$32.2M
Host factors regulating HIV latency and reactivationR37AI165137 · NIAID · UNIVERSITY OF FLORIDA · PI Susana T Valente · 2022 to 2026
$2.0M
Identification and characterization of chromatin regulators of HIV-1 latencyR33AI140439 · NIAID · UNIVERSITY OF FLORIDA · PI VALENTE, SUSANA T · 2021 to 2022
$1.8M
Miami Center for AIDS Research P30AI073961NIAID NIH HHS R33 AI140439NIAID NIH HHS R37 AI165137NIAID NIH HHS UM1 AI164559NIH
6 · The paper itself

Abstract

HIV transcription is amplified by the viral transactivator Tat, yet two quantitative issues remain unresolved in chromatin: the extent to which host machinery sustains transcription in the absence of Tat, and why Tat's widespread chromatin association yields limited host-gene output. We engineered an isogenic Tat-deficient derivative of the HIVGKO dual-reporter virus that preserves native proviral architecture, enabling longitudinal measurements across diverse integration sites in primary CD4⁺ T cells and Jurkat cells. Across thousands of proviruses, host factors alone supported a restricted baseline, with Tat-null proviruses producing ∼4%-15% of wild-type protein output and remaining constrained under strong stimulation. Chromatin immunoprecipitation-seq profiling revealed that Tat is dispensable for promoter-proximal RNAPII engagement and pausing but required for efficient CDK9 recruitment, Ser2 phosphorylation, and productive elongation, defining a ceiling for Tat-independent transcription. Tat deficiency reduced overall RNAPII occupancy without increased promoter-proximal accumulation. Genome-wide mapping using Tat-null controls revealed broad Tat association with active host loci and modest increases in elongation-factor occupancy; however, host-gene RNA gains were small (∼1.05-1.49×) and poorly correlated with Tat binding. Instead, elongation-associated chromatin features better predicted responsiveness. Together, these findings define a framework separating host-driven transcription from Tat-dependent scaling and explain Tat's disproportionate potency at the provirus.

Indexed as

HIV-1Host-Pathogen Interactionstat Gene Products, Human Immunodeficiency VirusTranscription, GeneticViral TranscriptionCD4-Positive T-LymphocytesChromatinCyclin-Dependent Kinase 9HumansJurkat CellsPromoter Regions, GeneticProvirusesRNA Polymerase IICDK9 protein, humanChromatinCyclin-Dependent Kinase 9RNA Polymerase IItat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID42328785
PMCPMC13284711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.